Rheumatology and Inflammatory Arthritis (ICRIA2-26)

This track will explore the latest breakthroughs in molecular diagnostics that enhance the understanding of rheumatic diseases. Emphasis will be placed on the integration of genomic and proteomic technologies in clinical practice.

This session will focus on novel therapeutic approaches for managing inflammatory arthritis, including biologics and small molecules. Discussions will highlight efficacy, safety, and patient-centered outcomes.

This track will delve into the immunological underpinnings of rheumatic diseases, examining how immune dysregulation contributes to pathology. Presentations will cover both basic research and clinical implications.

This session will emphasize the importance of translational research in bridging laboratory findings with clinical applications in rheumatology. Participants will discuss successful case studies and future directions.

This track will address the principles and practices of patient-centered care in the management of rheumatic diseases. Topics will include shared decision-making, patient education, and quality of life assessments.

This session will highlight recent advancements in biomarker discovery relevant to rheumatic diseases. Discussions will focus on the potential of biomarkers for diagnosis, prognosis, and treatment response.

This track will provide insights into the clinical management of complex rheumatologic conditions, including comorbidities and treatment challenges. Expert panels will share best practices and case studies.

This session will cover cutting-edge laboratory techniques utilized in rheumatology research, including imaging, histopathology, and molecular assays. Participants will gain insights into methodological advancements and their applications.

This track will examine the epidemiological aspects of rheumatic diseases and their impact on public health. Discussions will include disease prevalence, risk factors, and health policy implications.

This session will focus on the unique challenges faced in the diagnosis and treatment of pediatric rheumatic diseases. Innovative approaches and emerging therapies will be discussed to enhance care for young patients.

This track will explore integrative approaches to rheumatology, combining conventional and complementary therapies. The focus will be on holistic patient care and the evidence supporting integrative practices.